title: The effect of recombinant human growth hormone therapy on left-ventricular chamber size and function in children with growth hormone deficiency.
abstract: This study was designed to assess the effect of recombinant human growth hormone (rhGH) therapy on left-ventricular (LV) chamber size and function in children with idiopathic isolated growth hormone deficiency (GHD) using conventional echocardiography and tissue Doppler imaging (TDI). Thirty patients (19 boys and 11 girls) with idiopathic isolated GHD were followed-up for 12 months. Mean age of patients was 11.0 ± 2.6 years (range 6.3-15.5). At baseline and at 3, 6, and 12 months of treatment, the structure of the left ventricle was assessed by conventional echocardiography and myocardial rates and time intervals by TDI. There was a significant increase in LV mass (LVM) compared with pretreatment values. Like LVM, relative wall thickness (RWT) was also increased significantly. The significant increase in LVM indexed to body surface area and RWT became apparent at month 3 of treatment with a significant increase in LVM indexed to height(2.7) at treatment month 6. Normalized LVM increased as early month 3 of treatment, and a steady increase was observed until month 12. However, no patient had LVM > +2 standard deviation scores at month 12 of treatment. No significant differences were observed in functional parameters of the left ventricle and the interventricular septum. The results of this study showed that rhGH therapy causes an increase in myocardial mass without changing the geometry or function of the myocardium. Therefore, the increase in myocardial mass appears to be concentric, thus causing remodeling instead of hypertrophy.
authors.affiliation: Department of Pediatric Endocrinology, Ankara Child's Health and Hematology Oncology Training Hospital, Irfan Bastug Cad. Kurtdereli Sok. No: 10, 06110, Altindag, Ankara, Turkey, esen_ihsan@yahoo.com.
authors.forename: Ihsan
authors.initials: I
authors.lastname: Esen
authors.forename: Ilker
authors.initials: I
authors.lastname: Cetin
authors.forename: Fatma
authors.initials: F
authors.lastname: Demirel
authors.forename: Filiz
authors.initials: F
authors.lastname: Ekici
mesh_terms: D000293:Adolescent; D002648:Child; D003430:Cross-Sectional Studies; D004393:Dwarfism, Pituitary / Q000188:drug therapy* / Q000503:physiopathology; D015150:Echocardiography, Doppler; D005260:Female; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D020249:Hormone Replacement Therapy / Q000379:methods*; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011994:Recombinant Proteins; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects*
chemical_list: D011994:Recombinant Proteins; D019382:Human Growth Hormone